CBD and the Pain of Getting Older: What New Research Says

Chronic pain in older adults is dramatically undertreated. A new review in Pharmacological Research explores whether the endocannabinoid system – and CBD – may hold part of the answer.

Pain Doesn’t Have to Be the Price of Getting Older

Ask most people over 60 what their biggest daily challenge is, and a large number will say pain. Osteoarthritis. Nerve damage from diabetes. Aching muscles and joints that just don’t bounce back the way they used to. Chronic, low-grade pain is so common in older adults that it’s often dismissed as simply part of aging.

It shouldn’t be. And a new comprehensive review published in Pharmacological Research (2026) argues that the body’s own endocannabinoid system – and phytocannabinoids like CBD – may offer a meaningful path forward.

The Science of “Inflammaging”

Here’s a concept worth knowing: inflammaging. As we age, the immune system loses some of its regulatory balance. The body produces a persistent, low-grade level of inflammation even when there’s nothing acutely wrong. This chronic inflammatory state drives many of the most common painful conditions of aging – from joint degeneration to nerve sensitivity to slower healing.

The endocannabinoid system (ECS) plays a direct role in moderating this inflammatory response. Cannabinoid receptors (CB1 and CB2) are distributed throughout the nervous system, immune cells, and peripheral tissues – exactly the places where age-related pain originates. As we get older, ECS tone can decline, leaving the body less equipped to regulate its own pain and inflammatory responses.

What CBD Brings to the Table

CBD interacts with the ECS in multiple ways, and the review by Pulone, Moulton, Nucera, Ilari, Muscoli, and Tasciotti explores this in clinical detail. Key mechanisms include:

• Anti-inflammatory action – CBD modulates the production of pro-inflammatory cytokines, potentially helping interrupt the inflammaging cycle
• Neuroprotection – CBD may protect peripheral nerves from the kind of degenerative damage that causes neuropathic pain
• Interaction with pain receptors – CBD influences TRPV1 receptors (the same receptors involved in heat and pain sensation), potentially raising the threshold at which pain signals are perceived
• Reduced opioid dependence potential – as older adults are disproportionately at risk from opioid side effects, the prospect of an effective, well-tolerated alternative is significant

A Population That Needs New Options Badly

Older adults face a painful paradox: they experience more chronic pain than any other age group, yet they’re also most vulnerable to the side effects of common pain medications. NSAIDs like ibuprofen can damage the kidneys and raise cardiovascular risk with long-term use. Opioids carry risks of dependence, falls, and cognitive impairment.

CBD’s well-documented safety profile – particularly the absence of respiratory depression, physical dependence, or significant cardiovascular effects at typical doses – makes it a pharmacologically compelling candidate for chronic pain management in aging populations.

Practical Takeaways

• Start low, go slow – older adults may be more sensitive to CBD’s effects and often benefit from starting with lower doses (10–25mg) and adjusting gradually
• Consistency matters – the ECS responds to sustained use; many older adults report the most benefit after 2–4 weeks of daily use
• Route of administration matters – sublingual CBD oil offers a faster onset than capsules or edibles, which may be preferable for more acute pain episodes
• Drug interactions – CBD can affect how certain medications are metabolized; always consult a healthcare provider, especially if taking blood thinners or other prescription medications

---

About the Original Study

Title: Therapeutic use of cannabinoids in age-related pain: Current evidence and clinical perspectives Year: 2026 Journal: Pharmacological Research, 225:108130 DOI: 10.1016/j.phrs.2026.108130 PubMed: https://pubmed.ncbi.nlm.nih.gov/41651319/

Authors – Multiple Italian academic institutions:

• Sabina Pulone – Magna Graecia University of Catanzaro
• Chantalle Moulton – Magna Graecia University of Catanzaro
• Saverio Nucera – Magna Graecia University of Catanzaro
• Sara Ilari – IRCCS San Raffaele Roma
• Carolina Muscoli – Magna Graecia University of Catanzaro
• Ennio Tasciotti – IRCCS San Raffaele Roma

---